BEGIN:VCALENDAR
VERSION:2.0
PRODID: -//Q4 Inc.//EN
METHOD:PUBLISH
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
ORGANIZER:MAILTO:investors@fortebiorx.com
DTSTART;TZID="America/New_York":20250623T000000
DTEND;TZID="America/New_York":20250623T000000
LOCATION:
UID:914f10df-50be-40bd-bf05-b10b47ec9b45
DTSTAMP:20260710T013931
SUMMARY:Forte Biosciences Webcast to Discuss Positive Data in FB102 Celiac Disease Phase 1B Study
DESCRIPTION: View More Information: https://www.fortebiorx.com/investor-relations/events-and-presentations/event-calendar/event-details/2025/Forte-Biosciences-Webcast-to-Discuss-Positive-Data-in-FB102-Celiac-Disease-Phase-1B-Study/default.aspx
URL;VALUE=URI:https://www.fortebiorx.com/investor-relations/events-and-presentations/event-calendar/event-details/2025/Forte-Biosciences-Webcast-to-Discuss-Positive-Data-in-FB102-Celiac-Disease-Phase-1B-Study/default.aspx
PRIORITY:5
CLASS:PUBLIC
END:VEVENT
END:VCALENDAR